Go ES,Urban C,Burns J,et al.Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymyxin B and sulbactam[J].Lancet,1994,344(8933):1329-1332.
[2]
Jeon BC,Jeonq SH,Bae IK,et al.Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23beta-lactamase in Korea[J].J Clin Microbiol,2005,43(5):2241-2245.
[3]
Naas T,Levy M,Hirschauer C,et al.Outbreak of carbapenem-resistant Acinetbacter baumannii producing the carbapenemase OXA-23 in a tertiary carehospital of Papeete,French Polynesia[J].J Clin Microbiol,2005,43(9):4825-4829.
Vila J,Marcos MA,Jimenez de Anta MT,et al.A comparative study of different PCR-based DNA fingerprinting techniques for typing of the Acinetobacter calcoaceticus-A.baumannii complex[J].Med Microbiol, 1996, 44(6): 482-489.
[7]
Rhomberg PR,Jones RN.Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program:a 10-year experience in the United States(1999—2008)[J].Diagnostic microbiology and infectious disease, 2009, 65(4): 414-426.
[8]
Johnson AP,Woodford N,Global spread of antibiotic resistance:the example of New Delhi metallo-beta-lactamase(NDM)-mediated carbapenem resistance[J].Journal of Medical Microbiology, 2013, 62(4): 499-513.
[9]
Jovcic B,Lepsanovic Z,Suljagic V,et al.Emergence of NDM-1 metallo-beta-lactamase in Pseudomonas aeruginosa clinical isolates from Serbia[J].Antimicrobial Agents and Chemotherapy, 2011, 55(8): 3929-3931.
[10]
Wang X,Xu X,Li Z,et al.An Outbreak of a nosocomial NDM-1-Producing KlebsieUa pneumoniae ST147 at a teaching hospital in Mainland China[J].Microbial Drug Resistance, 2014, 20(2): 144-149.
[11]
Yang J,Chen Y,Jia X,et al.Dissemination and characterization of NDM-1-producing Acinetobacter pittii in an intensive care unit in China[J].Clinical Microbiology and Infection, 2012, 18(12): E506-E513.
[12]
Fu Y,Du X,Ji J,et al.Epidemiological characteristics and genetic structure of blaNDM-1 in non-baumannii Acinetobacter spp.in China[J].The Journal of Antimicrobial Chemotherapy, 2012, 67(9): 2114-2122.
[13]
Chen Y,Zhou Z,Jiang Y,et al.Emergence of NDM-1-producing Acinetobacter baumannii in China[J].The Journal of Antimicrobial Chemotherapy, 2011, 66(6): 1255-1259.
[14]
Gales AC,Jones RN,Sader HS,et al.Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli:report from the SENTRY antimicrobial surveillance programme(2001—2004)[J].Clinical Microbiology and Infection, 2006, 12(4): 315-321.
[15]
Gales AC,Jones RN,Sader HS,et al.Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens:results from the SENTRY Antimicrobial Surveillance Program(2006-09)[J].The Journal of Antimicrobial Chemotherapy, 2011, 66(9): 2070-2074.
